These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33383743)

  • 21. Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit.
    Porkoláb G; Mészáros M; Tóth A; Szecskó A; Harazin A; Szegletes Z; Ferenc G; Blastyák A; Mátés L; Rákhely G; Deli MA; Veszelka S
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32645904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.
    Mészáros M; Phan THM; Vigh JP; Porkoláb G; Kocsis A; Páli EK; Polgár TF; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA; Veszelka S
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review.
    Ansari MA; Chung IM; Rajakumar G; Alzohairy MA; Alomary MN; Thiruvengadam M; Pottoo FH; Ahmad N
    Curr Pharm Des; 2020; 26(11):1128-1137. PubMed ID: 31951165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier.
    Yan F; Wang Y; He S; Ku S; Gu W; Ye L
    J Mater Sci Mater Med; 2013 Oct; 24(10):2371-9. PubMed ID: 23793566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.
    Wagner S; Zensi A; Wien SL; Tschickardt SE; Maier W; Vogel T; Worek F; Pietrzik CU; Kreuter J; von Briesen H
    PLoS One; 2012; 7(3):e32568. PubMed ID: 22396775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
    Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
    Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
    Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoscale drug delivery systems and the blood-brain barrier.
    Alyautdin R; Khalin I; Nafeeza MI; Haron MH; Kuznetsov D
    Int J Nanomedicine; 2014; 9():795-811. PubMed ID: 24550672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
    Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
    Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances and Opportunities in Nanoparticle Drug Delivery for Central Nervous System Disorders: A Review of Current Advances.
    Ekhator C; Qureshi MQ; Zuberi AW; Hussain M; Sangroula N; Yerra S; Devi M; Naseem MA; Bellegarde SB; Pendyala PR
    Cureus; 2023 Aug; 15(8):e44302. PubMed ID: 37649926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E.
    Neves AR; Queiroz JF; Weksler B; Romero IA; Couraud PO; Reis S
    Nanotechnology; 2015 Dec; 26(49):495103. PubMed ID: 26574295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery.
    Fateh Basharzad S; Hamidi M; Maleki A; Karami Z; Mohamadpour H; Reza Saghatchi Zanjani M
    Brain Res; 2022 Apr; 1781():147786. PubMed ID: 35041841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy.
    Martins C; Araújo F; Gomes MJ; Fernandes C; Nunes R; Li W; Santos HA; Borges F; Sarmento B
    Eur J Pharm Biopharm; 2019 May; 138():111-124. PubMed ID: 29397261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review.
    Singh M; Mazumder B
    Pharm Nanotechnol; 2022; 10(1):42-55. PubMed ID: 34951376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.